Serum glial cell line-derived neurotrophic factor levels and impulsivity in heroin addiction: a cross-sectional, case-control study of 129 heroin addicts

References

• Beck KD, Valverde J, Alexi T, et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 1995;373:339–341. doi: 10.1038/373339a0
   PubMed Web of Science ®Google Scholar
• Kearns CM, Gash DM. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 1995;672:104–111. doi: 10.1016/0006-8993(94)01366-P
   PubMed Web of Science ®Google Scholar
• Lin LF, Doherty DH, Lile JD, et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 1993;260:1130–1132. doi: 10.1126/science.8493557
   PubMed Web of Science ®Google Scholar
• Sauer H, Rosenblad C, Björklund A. Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA. 1995;92:8935–8939. doi: 10.1073/pnas.92.19.8935
   PubMed Web of Science ®Google Scholar
• Aoi M, Tomita S, Ohmoto T. Single administration of GDNF into the striatum induced protection and repair of the nigrostriatal dopaminergic system in the intrastriatal 6-hydroxydopamine injection model of hemiparkinsonism. Restor Neurol Neurosci. 2000;17:31–38.
   Web of Science ®Google Scholar
• Mickiewicz AL, Kordower JH. GDNF family ligands: a potential future for Parkinson’s disease therapy. CNS Neurol Disord Drug Targets. 2011;10:703–711. doi: 10.2174/187152711797247876
   Web of Science ®Google Scholar
• Ron D, Janak PH. GDNF and addiction. Rev Neurosci. 2005;16:277–286. doi: 10.1515/REVNEURO.2005.16.4.277
   PubMed Web of Science ®Google Scholar
• Numan S, Lane-Ladd SB, Zhang L, et al. Differential regulation of neurotrophin and trk receptor mRNAs in catecholaminergic nuclei during chronic opiate treatment and withdrawal. J Neurosci. 1998;18:10700–10708.
   Web of Science ®Google Scholar
• Barak S, Carnicella S, Yowell QV, et al. Glial cell line-derived neurotrophic factor reverses alcohol-induced allostasis of the mesolimbic dopaminergic system: implications for alcohol reward and seeking. J Neurosci. 2011;31:9885–9894. doi: 10.1523/JNEUROSCI.1750-11.2011
   Web of Science ®Google Scholar
• Green-Sadan T, Kuttner Y, Lublin-Tennenbaum T, et al. Glial cell line-derived neurotrophic factor-conjugated nanoparticles suppress acquisition of cocaine self-administration in rats. Exp Neurol. 2005;194:97–105. doi: 10.1016/j.expneurol.2005.01.020
   Web of Science ®Google Scholar
• Messer CJ, Eisch AJ, Carlezon WA, et al. Role for GDNF in biochemical and behavioral adaptations to drugs of abuse. Neuron. 2000;26:247–257. doi: 10.1016/S0896-6273(00)81154-X
   PubMed Web of Science ®Google Scholar
• Carnicella S, Amamoto R, Ron D. Excessive alcohol consumption is blocked by glial cell line-derived neurotrophic factor. Alcohol. 2009;43:35–43. doi: 10.1016/j.alcohol.2008.12.001
   PubMed Web of Science ®Google Scholar
• Winkler C, Sauer H, Lee CS, et al. Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson’s disease. J Neurosci. 1996;16:7206–7215.
   PubMed Web of Science ®Google Scholar
• Caspi A. The child is father of the man: personality continuities from childhood to adulthood. J Pers Soc Psychol. 2000;78:158–172. doi: 10.1037/0022-3514.78.1.158
   PubMed Web of Science ®Google Scholar
• Fergusson DM, Boden JM, Horwood LJ. Recurrence of major depression in adolescence and early adulthood, and later mental health, educational and economic outcomes. Br J Psychiatry. 2007;191:335–342. doi: 10.1192/bjp.bp.107.036079
   PubMed Web of Science ®Google Scholar
• Pompili M, Innamorati M, Lester D, et al. Substance abuse, temperament and suicide risk: evidence from a case-control study. J Addict Dis. 2009;28:13–20. doi: 10.1080/10550880802544757
   PubMed Web of Science ®Google Scholar
• Dawe S, Gullo MJ, Loxton NJ. Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse. Addict Behav. 2004;29:1389–1405. doi: 10.1016/j.addbeh.2004.06.004
   PubMed Web of Science ®Google Scholar
• Nicola M D, Tedeschi D, De Risio L, et al. Co-occurrence of alcohol use disorder and behavioral addictions: relevance of impulsivity and craving. Drug Alcohol Depend. 2015;148:118–125. doi: 10.1016/j.drugalcdep.2014.12.028
   Web of Science ®Google Scholar
• Moeller FG, Barratt ES, Dougherty DM, et al. Psychiatric aspects of impulsivity. Am J Psychiatry. 2001;158:1783–1793. doi: 10.1176/appi.ajp.158.11.1783
   PubMed Web of Science ®Google Scholar
• Patton JH, Stanford MS. Factor structure of the Barratt impulsiveness scale. J Clin Psychol. 1995;51:768–774. doi: 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Güleç H, Tamam L, Güleç MY, et al. Psychometric properties of the Turkish version of the Barratt impulsiveness scale-11. Klinik Psikofarmakoloji Bülteni. 2008;18:251–258.
   Google Scholar
• Pascual A, Hidalgo-Figueroa M, Piruat JI, et al. Absolute requirement of GDNF for adult catecholaminergic neuron survival. Nat Neurosci. 2008;11:755–761. doi: 10.1038/nn.2136
   PubMed Web of Science ®Google Scholar
• Ma X-c, Chen C, Zhu F, et al. Association of the GDNF gene with depression and heroin dependence, but not schizophrenia, in a Chinese population. Psychiatry Res. 2013;210:1296–1298. doi: 10.1016/j.psychres.2013.08.025
   Web of Science ®Google Scholar
• Takebayashi M, Hisaoka K, Nishida A, et al. Decreased levels of whole blood glial cell line-derived neurotrophic factor (GDNF) in remitted patients with mood disorders. Int J Neuropsychopharmacol. 2006;9:607–612. doi: 10.1017/S1461145705006085
   PubMed Web of Science ®Google Scholar
• Barbosa IG, Huguet RB, Sousa LP, et al. Circulating levels of GDNF in bipolar disorder. Neurosci Lett. 2011;502:103–106. doi: 10.1016/j.neulet.2011.07.031
   PubMed Web of Science ®Google Scholar
• Barak S, Ahmadiantehrani S, Kharazia V, et al. Positive autoregulation of GDNF levels in the ventral tegmental area mediates long-lasting inhibition of excessive alcohol consumption. Transl Psychiatry. 2011;1:e60. doi: 10.1038/tp.2011.57
   Web of Science ®Google Scholar
• Carnicella S, Ron D. GDNF—a potential target to treat addiction. Pharmacol Ther. 2009;122:9–18. doi: 10.1016/j.pharmthera.2008.12.001
   PubMed Web of Science ®Google Scholar
• Migliore M, Ortiz R, Dye S, et al. Neurotrophic and neuroprotective efficacy of intranasal GDNF in a rat model of Parkinson’s disease. Neuroscience. 2014;274:11–23. doi: 10.1016/j.neuroscience.2014.05.019
   PubMed Web of Science ®Google Scholar
• Kotyuk E, Nemeth N, Ronai Z, et al. Association between smoking behaviour and genetic variants of glial cell line-derived neurotrophic factor. J Genet. 2016;95:811–818. doi: 10.1007/s12041-016-0701-7
   PubMed Web of Science ®Google Scholar
• Kopra JJ, Panhelainen A, af Bjerkén S, et al. Dampened amphetamine-stimulated behavior and altered dopamine transporter function in the absence of brain GDNF. J Neurosci. 2017;37:1581–1590. doi: 10.1523/JNEUROSCI.1673-16.2016
   Web of Science ®Google Scholar
• Michelato A, Bonvicini C, Ventriglia M, et al. 3′ UTR (AGG) n repeat of glial cell line-derived neurotrophic factor (GDNF) gene polymorphism in schizophrenia. Neurosci Lett. 2004;357:235–237. doi: 10.1016/j.neulet.2003.12.089
   Web of Science ®Google Scholar
• Chao MV. Neurotrophins and their receptors: a convergence point for many signalling pathways. Nat Rev Neurosci. 2003;4:299–309. doi: 10.1038/nrn1078
   PubMed Web of Science ®Google Scholar
• Verdejo-García A, Lawrence AJ, Clark L. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev. 2008;32:777–810. doi: 10.1016/j.neubiorev.2007.11.003
   PubMed Web of Science ®Google Scholar
• Dawe S, Loxton NJ. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev. 2004;28:343–351. doi: 10.1016/j.neubiorev.2004.03.007
   PubMed Web of Science ®Google Scholar
• Ghitza UE, Zhai H, Wu P, et al. Role of BDNF and GDNF in drug reward and relapse: a review. Neurosci Biobehav Rev. 2010;35:157–171. doi: 10.1016/j.neubiorev.2009.11.009
   PubMed Web of Science ®Google Scholar